BIRMF (Biorem) EBIT: $4.86 Mil (TTM As of Mar. 2026)


BIRMF Biorem Inc BIRMF
88 GF Score
Price $2.19
GF Value $1.93
Valuation Modestly Overvalued
View Full Analysis

What is Biorem EBIT?

Biorem BIRMF +0.39% 88 EBIT is $4.86 Mil as of Mar. 2026. GuruFocus rates BIRMF with a GF Score™ of 88/100 and a GF Value™ of $1.93 (Modestly Overvalued).

Biorem's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $0.22 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $4.86 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Biorem's annualized ROC % for the quarter that ended in Mar. 2026 was 4.28%. Biorem's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 40.01%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Biorem's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 16.06%.


Biorem  (OTCPK:BIRMF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Biorem's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=0.54 * ( 1 - 26.26% )/( (8.277 + 10.316)/ 2 )
=0.398196/9.2965
=4.28 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Biorem's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=0.896/( ( (1.324 + max(-0.009000000000003, 0)) + (1.473 + max(1.682, 0)) )/ 2 )
=0.896/( ( 1.324 + 3.155 )/ 2 )
=0.896/2.2395
=40.01 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(8.67 + 0.992 + 1.796) - (7.722 + 3.327 + 0.418)
=-0.009000000000003

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6.762 + 1.71 + 3.12) - (5.394 + 4.079 + 0.437)
=1.682

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Biorem's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=4.864/30.279
=16.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biorem EBIT Related Terms


Biorem EBIT Historical Data

* Premium members only.

The historical data trend for Biorem's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biorem EBIT Chart

Biorem Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.62 1.94 2.28 3.05 4.71

Biorem Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.77 1.17 2.70 0.22

BIRMF vs VLTO, ZWS, CECO: EBIT Comparison

For the Pollution & Treatment Controls subindustry, Biorem's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biorem EV-to-EBIT vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Biorem's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Biorem's EV-to-EBIT falls into.


BIRMF
88GF Score
Biorem Inc BIRMF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biorem EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $4.86 Mil mean?
Biorem (BIRMF) has a EBIT of $4.86 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Biorem.
Is Biorem's EBIT too high?
Biorem's current EBIT is $4.86 Mil. Overall, Biorem has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biorem's EBIT compare to VLTO and ZWS?
Biorem's EBIT of $4.86 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for an Industrial Products company?
A good EBIT depends on the Industrial Products industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Biorem. Biorem's current EBIT is $4.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biorem stock overvalued right now?
Based on GuruFocus' analysis, Biorem (BIRMF) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.93, compared to a current price of $2.19 — trading 13.5% above its estimated fair value. The current EBIT is $4.86 Mil. Biorem's overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Biorem (BIRMF), the current EBIT is $4.86 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biorem (BIRMF) Overvalued in 2026?

Based on GuruFocus' analysis, Biorem stock appears to be overvalued. The current stock price of $2.19 is trading 13.5% above its estimated GF Value™ of $1.93. GuruFocus considers Biorem to be Modestly Overvalued.

Key valuation signals for BIRMF:

  • EBIT: $4.86 Mil
  • GF Value™: $1.93 vs. price of $2.19 (13.5% above fair value)
  • GF Score™: 88/100

No single metric tells the full story. See the BIRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biorem Business Description

Other Exchanges R6D:GermanyBRM:Canada
Address 7496 Wellington Road 34, RR Number 3, Puslinch, Guelph, ON, CAN, N1H 6H9
Biorem Inc is an environmental biotechnology company. It is involved in the manufacturing of a comprehensive line of high efficiency air pollution control systems that are used to eliminate odorous and harmful contaminants. The company's products include Biofilters, Biogas Solutions, Multi-Stage Systems, Biotrickling filters, and services such as Media Sampling and Analysis, Biological processes and testing, Media replacements and Spare parts, and other related services. The company derives revenues from the sale of standard products, construction projects for specialized products, and services for repairs and maintenance. The group has a business presence in Canada, the United States, China and others, of which key revenue is derived from the United States.
88GF Score

Get the complete analysis for BIRMF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.19
Price
$1.93
GF Value